Netherlands· NL-0cd28f6c7e29
Mindavit 7000 IE filmomhulde tabletten
A colecalciferol product containing cholecalciferol + cholecalciferol concentraat, poedervorm, registered in Netherlands by Pharma Patent Kft.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Colecalciferol is registered in 16 of 19 countries.
Countries holding a registration under ATC A11CC05 (colecalciferol), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Colecalciferol · ATC A11CC05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CHOLECALCIFEROL + CHOLECALCIFEROL CONCENTRAAT, POEDERVORM
- Manufacturer
- Pharma Patent Kft.
- Country
- Netherlands (NL)
- ATC code
- A11CC05
- ATC class
- Colecalciferol
- Defined daily dose
- 20 mcg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id121582
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
68 interactions on record for colecalciferol.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Colecalciferol · interactions on record
68 records
- 10 severe
- 56 moderate
- 2 minor
Most severe, free to view
- ErgocalciferolA11CC01severe
- DihydrotachysterolA11CC02severe
- CalcitriolA11CC04severe
- CalcifediolA11CC06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Colecalciferol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAace D3 10,000unit capsulesEssential-Healthcare Ltd
- ItalyANNISTERISTITUTO BIOCHIMICO NAZIONALE SAVIO S.R.L.
- GermanyCholecalciferol 089pharmPharma Patent Kft.
- PolandANNEXXOI.B.N. Savio S.r.l.
- BelgiumAclonia 70 mg - 2800 IUPharmathen
- SpainALDEXINA 25.000 UI CÁPSULAS DURASLaboratorios Alter S.A.
- SwitzerlandD3 VitaCaps
- CzechiaDEPROVITAXONIA, a.s., Praha
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Colecalciferol Fresenius, Colecalciferol Invos
- Belgium · Colecaps, D-Cure
- Bulgaria · D-Vital, Dekristol
- Cyprus · Cholecalciferol Aviral, Deltius
- Czechia · Deprovit, Ditralia
- Germany · Cholecalciferol 089pharm, Cholecalciferol Mibe
- Denmark · Benferol, Cholecalciferol Strides
- Estonia · Adervia, Boncel
- Spain · Aldexina, Benferol
- Finland · Divifarm, Divisun
- France · Adrigyl, Cholecalciferol
- United Kingdom (Northern Ireland) · Aviticol, Cholecalciferol Zentiva
- Greece · Adapton D, Calcifenov
- Croatia · D-Vital, Dekristol
- Hungary · Colecalciferol Farmaprojects, D-Vitamin Eurovit
- Ireland · Altavitad3, Cholecalciferol Strides Pharma Cyprus
- Italy · Annexxo, Annister
- Lithuania · Adervia, Aquadetrim
- Luxembourg · Cholécalciférol Fultivit-D3, D-Cure
- Latvia · Adervia, Boncel
- Malta · Altavitad3, Cholecalciferol Pharmacare
- Norway · Benferol, Cholecalciferol Afortas
- Poland · Apod3 Med, Boncel
- Portugal · Aldexina, Colecalciferol
- Romania · Bonfal, Vigantol Oil
- Sweden · Benferol, Cholecalciferol Afortas
- Slovenia · Docile, Holekalciferol Krka
- Slovakia · Fultium, Olvit D3
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e96c0286-7b0c-42c4-8a15-063c7ff5f8cd GET /v1/drugs/e96c0286-7b0c-42c4-8a15-063c7ff5f8cd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h121582_smpc.pdf",
"strength": null,
"atc_label": "Colecalciferol",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg121582",
"excipients": [
"CELLULOSE, GEPOEDERD (E 460(ii))",
"CHINOLINEGEEL ALUMINIUMLAK (E 104)",
"CROSCARMELLOSE NATRIUM (E 468)",
"IJZEROXIDE GEEL (E 172)",
"LACTOSE 1-WATER",
"MACROGOL 3350",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"NATRIUMASCORBAAT (E 301)",
"POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
"SACCHAROSE",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)",
"TOCOFEROL, DL-ALFA (E 307)",
"TRIGLYCERIDEN MIDDELLANGE KETEN",
"ZETMEEL, GEMODIFICEERD (MODIFICATIE ONBEKEND) (E 1440)"
],
"substances": [
"CHOLECALCIFEROL",
"CHOLECALCIFEROL CONCENTRAAT, POEDERVORM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h121582.pdf",
"authorised_at": "2018/08/27",
"procedure_number": "NL/H/4075/003",
"dispensing_status": "Uitsluitend recept",
"registration_number": "121582",
"additional_monitoring": "N"
}See everything about colecalciferol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.